The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, sold 1,70,000 equity shares (0.10% of paid-up capital) through the open market on September 1-2, 2025. His individual holding fell from 3.11% (50,67,020 shares) to 3.01% (48,97,020 shares). Including persons acting in concert — Rohan Rashi Family Trust (3.69%), Mrs. Mona Kailash Choudhari (1.84%), Mr. Rohan Kailash Choudhari (0.09%), and Ms. Rashi Choudhari (0.09%) — the promoter group's combined stake is 5.71% (93,01,000 shares). The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011.
The sale is very small at just 0.10% of the company's share capital and the promoter group remains a meaningful shareholder at 5.71%. This is a routine insider trading disclosure and unlikely to materially affect the stock price or alter the company's ownership structure.